Advagen FDA Friday, June 28, 2019 0.00 Neutral

FDA Approves TRAMADOL HYDROCHLORIDE — Advagen Pharma Limited

Advagen Pharma Limited has gained FDA approval for its oral Tramadol Hydrochloride tablets, granting the company entry into the generic market for a widely prescribed analgesic and increasing competition within the space.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day